Accordingly, this review focuses specifically on PCa, emphasizing PSMA‐targeted delivery, strategies to overcome castration resistance, and the integration of nanoparticles with ADT, poly(ADP‐ribose) polymerase (PARP) inhibitors, and immunotherapy. This evidence concerns the gene FOLH1 and posterior cortical atrophy.